Early research (Phase 1)Study completedNCT03335540
What this trial is testing
An Adaptive Study to Match Patients With Solid Tumors to Various Immunotherapy Combinations Based Upon a Broad Biomarker Assessment
Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 20